Peritonitis activates transcription of the human prolactin locus in myeloid cells in a humanized transgenic rat model

Endocrinology

Volumn 153, Issue 6, 2012, Pages 2724-2734

  Semprini, Sabrina ^a   McNamara, Anne V ^d,e   Awais, Raheela ^d,e   Featherstone, Karen ^e   Harper, Claire V ^d,e   McNeilly, Judith R ^b   Patist, Amanda ^e   Rossi, Adriano G ^c   Dransfield, Ian ^c   McNeilly, Alan S ^b   Davis, Julian R E ^e   White, Michael R H ^d,e   Mullins, John J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC Reproductive Biology Unit   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; LUCIFERASE; THIOGLYCOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN CELL; HYPOPHYSIS; LYMPHOCYTE; MACROPHAGE; MONOCYTE; NEUTROPHIL; NONHUMAN; PERITONEUM EXUDATE; PERITONITIS; PRIORITY JOURNAL; PRL GENE; PROMOTER REGION; RAT; TRANSCRIPTION INITIATION; TRANSGENIC RAT;

ANIMALS; ANTIGENS, CD11B; BONE MARROW CELLS; CELLS, CULTURED; GENE EXPRESSION; HUMANS; LIPOPOLYSACCHARIDES; LUCIFERASES; MACROPHAGES; MICROSCOPY, FLUORESCENCE; MONOCYTES; MYELOID CELLS; NEUTROPHILS; PERITONITIS; PROLACTIN; RATS; RATS, TRANSGENIC; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOGLYCOLATES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861313344     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1926     Document Type: Article

References (50)

1. Ben-Jonathan N, LaPensee CR, LaPensee EW 2008 What can we learn from rodents about prolactin in humans? Endocr Rev 29:1-41 (Pubitemid 351252745)
2. Bernichtein S, Touraine P, Goffin V 2010 New concepts in prolactin biology. J Endocrinol 206:1-11
3. Emera D, Casola C, Lynch VJ, Wildman DE, Agnew D, Wagner GP 2012 Convergent evolution of endometrial prolactin expression in primates, mice, and elephants through the independent recruitment of transposable elements. Mol Biol Evol 29:239-247
4. Gellersen B, Kempf R, Telgmann R, DiMattia GE 1994 Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol Endocrinol 8:356-373 (Pubitemid 24108363)
5. Berwaer M, Martial JA, Davis JR 1994 Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene. Mol Endocrinol 8:635-642 (Pubitemid 24174500)
6. Lynch VJ, Tanzer A, Wang Y, Leung FC, Gellersen B, Emera D, Wagner GP 2008 Adaptive changes in the transcription factor HoxA-11 are essential for the evolution of pregnancy in mammals. Proc Natl Acad Sci USA 105:14928-14933
7. Lynch VJ, Brayer K, Gellersen B, Wagner GP 2009 HoxA-11 and FOXO1A cooperate to regulate decidual prolactin expression: towards inferring the core transcriptional regulators of decidual genes. PLoS One 4:e6845
8. Shaw-Bruha CM, Pirrucello SJ, Shull JD 1997 Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Res Treat 44:243-253 (Pubitemid 27296384)
9. Dagvadorj A, Collins S, Jomain JB, Abdulghani J, Karras J, Zellweger T, Li H, Nurmi M, Alanen K, Mirtti T, Visakorpi T, Bubendorf L, Goffin V, Nevalainen MT 2007 Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway. Endocrinology 148:3089-3101 (Pubitemid 46996970)
10. Prigent-Tessier A, Tessier C, Hirosawa-Takamori M, Boyer C, Ferguson-Gottschall S, Gibori G 1999 Rat decidual prolactin. Identification, molecular cloning, and characterization. J Biol Chem 274: 37982-37989 (Pubitemid 30026867)
11. Nevalainen MT, Valve EM, Ahonen T, Yagi A, Paranko J, Härkönen PL 1997 Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J 11: 1297-1307 (Pubitemid 27527893)
12. Soares MJ 2004 The prolactin and growth hormone families: pregnancy-specific hormones/cytokines at the maternal-fetal interface. Reprod Biol Endocrinol 2:51
13. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268 (Pubitemid 29117815)
14. Gala RR, Shevach EM 1993 Identification by analytical flow cytometry of prolactin receptors on immunocompetent cell populations in the mouse. Endocrinology 133:1617-1623 (Pubitemid 23295187)
15. GagneraultMC,Touraine P, SavinoW,Kelly PA, DardenneM1993 Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 150:5673-5681 (Pubitemid 23180681)
16. Reuwer AQ, van Eijk M, Houttuijn-Bloemendaal FM, van der Loos CM, Claessen N, Teeling P, Kastelein JJ, Hamann J, Goffin V, von der Thüsen JH, Twickler MT, Aten J 2011 The prolactin receptor is expressed in macrophages within human carotid atherosclerotic plaques: a role for prolactin in atherogenesis? J Endocrinol 208: 107-117
17. Buckley AR 2001 Prolactin, a lymphocyte growth and survival factor. Lupus 10:684-690 (Pubitemid 33041660)
18. Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL 2001 Cytokine-like effects of prolactin in human mononuclear and polymor-phonuclear leukocytes. J Neuroimmunol 120:58-66 (Pubitemid 33016725)
19. Buckley AR, Buckley DJ 2000 Prolactin regulation of apoptosis-associated gene expression in T cells. Ann NY Acad Sci 917:522-533
20. Legorreta-Haquet MV, Chávez-Rueda K, Montoya-Díaz E, Arriaga- Pizano L, Silva-García R, Chávez-Sánchez L, Moreno-Lafont M, Zenteno-Galindo E, Blanco-Favela F 2012 Prolactin down-regulates CD4+CD25hiCD127low/- regulatory T cell function in humans. J Mol Endocrinol 48:77-85
21. Carvalho-Freitas MI, Rodrigues-Costa EC, Nasello AG, Palermo-Neto J, Felicio LF 2008 In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation. Neuroimmunomodulation 15:131-139
22. Krishnan N, Thellin O, Buckley DJ, Horseman ND, Buckley AR 2003 Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology 144:2102-2110 (Pubitemid 36543351)
23. Zhang WC, Sun R, Zhang J, Zhang J, Tian Z 2005 Recombinant human prolactin protects against irradiation-induced myelosuppression. Cell Mol Immunol 2:379-385
24. Sun R, Gault RA, Welniak LA, Tian ZG, Richards S, Murphy WJ 2003 Immunologic and hematopoietic effects of recombinant human prolactin after syngeneic bone marrow transplantation in mice. Biol Blood Marrow Transplant 9:426-434 (Pubitemid 38351800)
25. Paraiba DB, Soares CR, Bartolini P, Arthuso FS, Borba EF, Bonfa E, Bronstein MD 2010 Lymphocytic prolactin does not contribute to systemic lupus erythematosus hyperprolactinemia. Clin Exp Rheumatol 28:866-872
26. Czuwara-Ladykowska J, Sicinska J, Olszewska M, Uhrynowska-Tyszkiewicz I, Rudnicka L 2006 Prolactin synthesis by lymphocytes from patients with systemic sclerosis. Biomed Pharmacother 60: 152-155 (Pubitemid 43870418)
27. Díaz L, Martínez-Reza I, García-Becerra R, González L, Larrea F, Méndez I 2011 Calcitriol stimulates prolactin expression in non-activated human peripheral blood mononuclear cells: breaking paradigms. Cytokine 55:188-194
28. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K 1997 Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926-6935 (Pubitemid 27520793)
29. Bouchard B, Ormandy CJ, Di Santo JP, Kelly PA 1999 Immune system development and function in prolactin receptor-deficient mice. J Immunol 163:576-582 (Pubitemid 29328058)
30. Matera L 1996 Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 59:599-614 (Pubitemid 26274402)
31. Semprini S, Friedrichsen S, Harper CV, McNeilly JR, Adamson AD, Spiller DG, Kotelevtseva N, Brooker G, Brownstein DG, McNeilly AS, White MR, Davis JR, Mullins JJ 2009 Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model. Mol Endocrinol 23:529-538
32. Friedrichsen S, Harper CV, Semprini S, Wilding M, Adamson AD, Spiller DG, Nelson G, Mullins JJ, White MR, Davis JR 2006 Tumor necrosis factor-α activates the human prolactin gene promoter via nuclear factor-κB signaling. Endocrinology 147:773-781 (Pubitemid 43112994)
33. Gibson UE, Heid CA, Williams PM 1996 A novel method for real time quantitative RT-PCR. Genome Res 6:995-1001 (Pubitemid 26388092)
34. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
35. Harper CV, Featherstone K, Semprini S, Friedrichsen S, McNeilly J, Paszek P, Spiller DG, McNeilly AS, Mullins JJ, Davis JR, WhiteMR 2010 Dynamic organisation of prolactin gene expression in living pituitary tissue. J Cell Sci 123:424-430
36. Beelen RH, Walker WS 1983 Dynamics of cytochemically distinct subpopulations of macrophages in elicited rat peritoneal exudates. Cell Immunol 82:246-257
37. Melnicoff MJ, Horan PK, Morahan PS 1989 Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol 118:178-191 (Pubitemid 19030960)
38. Qureshi R, JakschikBA1988 The role of mast cells in thioglycollate- induced inflammation. J Immunol 141:2090-2096
39. Gingras MC, Margolin JF 2000 Differential expression of multiple unexpected genes during U937 cell and macrophage differentiation detected by suppressive subtractive hybridization. Exp Hematol 28: 65-76 (Pubitemid 30047192)
40. De Laurentiis A, Pisera D, Caruso C, Candolfi M, Mohn C, Rettori V, Seilicovich A 2002 Lipopolysaccharide- and tumor necrosis factor-α-induced changes in prolactin secretion and dopaminergic activity in the hypothalamic-pituitary axis. Neuroimmunomodulation 10:30-39 (Pubitemid 35007463)
41. Rettori V, Dees WL, Hiney JK, Lyson K, McCann SM 1994 An interleukin-1-α-like neuronal system in the preoptic-hypothalamic region and its induction by bacterial lipopolysaccharide in concentrations which alter pituitary hormone release. Neuroimmuno-modulation 1:251-258
42. Corbacho AM, Valacchi G, Kubala L, Olano-Martín E, Schock BC, Kenny TP, Cross CE 2004 Tissue-specific gene expression of prolactin receptor in the acute-phase response induced by lipopolysac-charides. Am J Physiol Endocrinol Metab 287:E750-E757 (Pubitemid 39237905)
43. Kooijman R, Gerlo S, Coppens A, Hooghe-Peters EL 2000 Growth hormone and prolactin expression in the immune system. Ann NY Acad Sci 917:534-540
44. Montgomery DW 2001 Prolactin production by immune cells. Lupus 10:665-675 (Pubitemid 33041658)
45. Thorat SP, Thatte UM, Pai N, Dahanukar SA 1993 Effect of prolactin on neutrophils and monocytes. Acta Haematol 89:219-220 (Pubitemid 23284616)
46. Zhu XH, Zellweger R, WichmannMW,Ayala A, Chaudry IH 1997 Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine 9:437-446 (Pubitemid 27249977)
47. Gerlo S, Verdood P, Kooijman R 2006 Tumor necrosis factor- αactivates the extrapituitary PRL promoter in myeloid leukemic cells. J Neuroimmunol 172:206-210 (Pubitemid 43277507)
48. Gerlo S, Vanden Berghe W, Verdood P, Hooghe-Peters EL, Kooijman R 2003 Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells. J Neuroimmunol 135:107-116 (Pubitemid 36170157)
49. Stevens A, Ray D, Alansari A, Hajeer A, Thomson W, Donn R, Ollier WE, Worthington J, Davis JR 2001 Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus. Arthritis Rheum 44:2358-2366 (Pubitemid 32977504)
50. Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, Padyukov L, Costenbader KH, Seielstad M, Graham RR, Klareskog L, Gregersen PK, Plenge RM, Karlson EW 2009 The PRL - 1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum 60:1250-1254